Incyte (INCY) Return on Invested Capital (2012 - 2026)

Incyte (INCY) posted Return on Invested Capital of 0.08% for Q1 2026, up 12.88% on a QoQ basis from 0.07% in Q4 2025, and up 8.0% year-over-year from 0.07% in Q1 2025.

Incyte (INCY) Return on Invested Capital (2012 - 2026) Analysis & Trends

Incyte's Return on Invested Capital history runs 14 years deep, the most recent figure standing at 0.08% for Q1 2026.

  • Quarterly Return on Invested Capital rose 8.0% year-over-year to 0.08% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.08% (up 8.0% YoY) and the FY2025 annual result came in at 0.32%, up 32.0% from the prior year.
  • Return on Invested Capital was 0.08% for Q1 2026 at Incyte, up from 0.07% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.08% in Q1 2026 and bottomed at 0.0% in Q3 2024.
  • A 5-year average of 0.04% and a median of 0.03% in 2023 frame the typical range for Return on Invested Capital.
  • Annual changes were most pronounced in 2023 — Return on Invested Capital fell 5 bps — and 2026, when it advanced 8 bps.
  • Incyte's Return on Invested Capital stood at 0.03% in 2022, then advanced by 19 bps to 0.03% in 2023, then plunged by 99 bps to 0.0% in 2024, then surged by 16189 bps to 0.07% in 2025, then increased by 13 bps to 0.08% in 2026.
  • Business Quant data shows INCY's Return on Invested Capital at 0.08% in Q1 2026, 0.07% in Q4 2025, and 0.07% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.00%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.04%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Incyte 23.33 Bn 19.32 Bn 1.17 Bn 0.08%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.08%
Dec 31, 2025 0.07%
Sep 30, 2025 0.07%
Jun 30, 2025 0.05%
Mar 31, 2025 0.00%
Dec 31, 2024 0.00%
Sep 30, 2024 0.00%
Jun 30, 2024 0.00%
Mar 31, 2024 0.03%
Dec 31, 2023 0.03%
Sep 30, 2023 0.02%
Jun 30, 2023 0.02%
Mar 31, 2023 0.02%
Dec 31, 2022 0.03%
Sep 30, 2022 0.06%
Jun 30, 2022 0.07%
Mar 31, 2022 0.06%
Dec 31, 2021 0.06%
Sep 30, 2021 0.04%
Jun 30, 2021 0.03%